System and Method for Estimating a Remaining Capacity of a Battery Granted to O2Micro
GEORGE TOWN, Grand Cayman, Aug. 03, 2020 (GLOBE NEWSWIRE) — O2Micro® International Limited (NASDAQ Global Select Market: OIIM), a global leader in the […]
FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex
– Age-range for all EPIDIOLEX indications expanded to include patients one year of age and older –– Third indication approved for […]
PolyPid Granted Fast Track Designation from FDA for D-PLEX₁₀₀ for Prevention of Surgical Site Infections in Abdominal Surgery
PETAH TIKVA, Israel, Aug. 03, 2020 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), a Phase 3 clinical-stage biopharmaceutical company focused […]
Microbot Medical Appoints the Co-Founder of Corindus Vascular Robotics to its Board of Directors
HINGHAM, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) has further strengthened the Company’s capabilities and […]
BMC Updates Date and Time for 2020 Second Quarter Results Conference Call and Webcast
RALEIGH, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) — BMC Stock Holdings, Inc. (Nasdaq: BMCH) (“BMC” or the “Company”), a leading […]
HOOKIPA Announces Issuance of US and European Patents
NEW YORK and VIENNA, Austria, Aug. 03, 2020 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing […]
Cerecor Receives Orphan Drug Designation for CERC-006 in Lymphatic Malformations
ROCKVILLE, Md. and CHESTERBROOK, Pa., Aug. 03, 2020 (GLOBE NEWSWIRE) — Cerecor Inc. (NASDAQ: CERC), a leading biopharmaceutical company in […]
Nabriva Therapeutics to Report Second Quarter 2020 Financial Results on August 6, 2020
DUBLIN, Ireland, Aug. 03, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization […]
Akoustis to Attend the IMS2020 Virtual Conference Event on August 4-6, 2020
– Showcasing Akoustis’ XBAW Technology and Filter Products –– BAW Filter Solutions for 5G Network Infrastructure, WiFi 6 & 6E […]
Precision BioSciences to Report Second Quarter 2020 Financial Results and Present at Upcoming Investor Conferences
DURHAM, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) — Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to […]
